Long-Term Treatment With Apremilast in Hidradenitis Suppurativa: A 2-Year Follow-Up of Initial Responders

    September 2020 in “ Journal of the American Academy of Dermatology ”
    Pim Aarts, Allard R.J.V. Vossen, Hessel H. van der Zee, Errol P. Prens, Kelsey R. van Straalen
    TLDR Apremilast may be a promising long-term treatment for hidradenitis suppurativa.
    The study followed initial responders from a randomized controlled trial of apremilast for hidradenitis suppurativa (HS) over 2 years. Initially, 53.3% of patients met the Hidradenitis Suppurativa Clinical Response (HiSCR) after 16 weeks of treatment. Of the 8 initial responders, 4 continued treatment for 2 years, all achieving HiSCR at follow-up visits. Two patients discontinued due to pregnancy wishes, and others due to side effects or symptom remission. Despite manageable side effects, 75% of participants would recommend apremilast. The study suggested prolonged efficacy of apremilast for HS, but emphasized the need for larger studies to confirm long-term benefits.
    Discuss this study in the Community →

    Related Community Posts Join

    3 / 3 results

      community DHT Harms Scalp Microbiome: DHT Itch is REAL

      in Research/Science  419 upvotes 8 months ago
      Increased Malassezia and Cutibacterium in the scalp microbiome are linked to higher sebum production and inflammation in androgenetic alopecia (AGA). Treatments include ciclopirox shampoo, benzoyl peroxide shampoo, clobetasol propionate, calcipotriol, minoxidil, finasteride, and dutasteride.

      community The Worst Hair Loss Condition You (MAY) have: LPP

      in Research/Science  43 upvotes 1 year ago
      Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

    Related Research

    1 / 1 results